MSD Netherlands Capital BV
MSD Netherlands Capital BV is a specialized financing subsidiary and debt-issuing vehicle for Merck & Co Inc, known outside the United States and Canada as MSD, a major American multinational pharmaceutical corporation. The company issues corporate bonds and debt instruments in European and international capital markets to fund the capital structure, strategic research and development initiatives, and refinancing requirements of Merck & Co operating entities worldwide. Merck & Co is a leading global healthcare enterprise discovering, developing, and delivering innovative prescription medicines, vaccines, biologic therapies, and animal health products. Cash flows servicing MSD Netherlands Capital's debt obligations are derived directly from intercompany loan repayments funded by the robust operating cash flows of Merck & Co's global pharmaceutical business. Merck & Co holds a dominant global market position in pharmaceuticals and life sciences. MSD Netherlands Capital BV is headquartered in Amsterdam, Netherlands.
8 of the funds FundTelligence covers report a position in MSD Netherlands Capital BV.
- Sector
- Financials
- Country
- Netherlands
- Funds holding it
- 8
Funds holding MSD Netherlands Capital BV
- Schroder ISF EURO Corporate Bond — Schroders · 1.1 % (full portfolio disclosed, June 2026)
- Schroder ISF EURO Credit Conviction — Schroders · 0.74 % (full portfolio disclosed, June 2026)
- Storebrand Global Corporate Bond IG 4-6Y — Storebrand · 0.5 % (full portfolio disclosed, October 2026)
- Storebrand Global Kreditt IG — Storebrand · 0.26 % (full portfolio disclosed, October 2026)
- Schroder ISF Sustainable Global Multi Credit — Schroders · 0.22 % (full portfolio disclosed, December 2025)
- KLP Obligasjon Global — KLP · 0.05 % (partially disclosed portfolio, June 2026)
- Schroder ISF Global Diversified Growth — Schroders · 0.01 % (full portfolio disclosed, June 2026)
- Schroder ISF Global Bond — Schroders · 0.01 % (full portfolio disclosed, June 2026)